A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02). This is an ASCO Meeting Abstract from ...

Passage Bio initiated a strategic review process after regulators didn't support a single-arm trial design for its dementia drug. The Food and Drug Administration indicated a randomized controlled ...

PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...

Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...

Google will partner with Included Health to launch a nationwide randomized study evaluating how conversational artificial intelligence performs in real-world virtual care workflows. Here are four ...